Joseph K Belanoff - Net Worth and Insider Trading
Joseph K Belanoff Net Worth
The estimated net worth of Joseph K Belanoff is at least $65 Million dollars as of 2024-04-28. Joseph K Belanoff is the CEO of Corcept Therapeutics Inc and owns about 2,831,918 shares of Corcept Therapeutics Inc (CORT) stock worth over $65 Million. Details can be seen in Joseph K Belanoff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph K Belanoff has not made any transactions after 2022-07-07 and currently still holds the listed stock(s).
Transaction Summary of Joseph K Belanoff
Joseph K Belanoff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph K Belanoff owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .
Click here to see the complete history of Joseph K Belanoff’s form 4 insider trades.
Insider Ownership Summary of Joseph K Belanoff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2022-07-07 | director & CHIEF EXECUTIVE OFFICER |
Joseph K Belanoff Latest Holdings Summary
Joseph K Belanoff currently owns a total of 1 stock. Joseph K Belanoff owns 2,831,918 shares of Corcept Therapeutics Inc (CORT) as of July 7, 2022, with a value of $65 Million.
Latest Holdings of Joseph K Belanoff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2022-07-07 | 2,831,918 | 22.80 | 64,567,730 |
Holding Weightings of Joseph K Belanoff
Joseph K Belanoff Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph K Belanoff has made a total of 1 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 335,019 shares on July 7, 2022, which brought Joseph K Belanoff around $9 Million.
Insider Trading History of Joseph K Belanoff
- 1
Joseph K Belanoff Trading Performance
Joseph K Belanoff Ownership Network
Ownership Network List of Joseph K Belanoff
Ownership Network Relation of Joseph K Belanoff
Joseph K Belanoff Owned Company Details
What does Corcept Therapeutics Inc do?
Who are the key executives at Corcept Therapeutics Inc?
Joseph K Belanoff is the director & CHIEF EXECUTIVE OFFICER of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Accounting Officer Joseph Douglas Lyon , See Remarks Sean Maduck , and Chief Development Officer William Guyer .
Corcept Therapeutics Inc (CORT) Insider Trades Summary
Over the past 18 months, Joseph K Belanoff made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 200,625 shares made by Sean Maduck , a net sale of 41,943 shares made by Joseph Douglas Lyon , and a net sale of 22,000 shares made by Swisher Daniel N Jr .
In summary, during the past 3 months, insiders sold 88,543 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 88,543 shares. During the past 18 months, 405,017 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 405,017 shares.
Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corcept Therapeutics Inc Insider Transactions
Joseph K Belanoff Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph K Belanoff. You might contact Joseph K Belanoff via mailing address: 149 Commonwealth Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
